7 assets in Testicular Germ Cell Tumor

Therapeutic assets addressing Testicular Germ Cell Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cldn6 Car-T Testicular Germ Cell Tumor	BioNTech SE	P2	CCC (53)
Cldn6 Rna-Lpx Testicular Germ Cell Tumor	BioNTech SE	P2	CCC (53)
Rain-32 Testicular Germ Cell Tumor	Rain Oncology Inc	P2	CCC (53)
Emunkitug Testicular Germ Cell Tumor	HiFiBiO Therapeutics	P1	CC (43)
Tislelizumab Testicular Germ Cell Tumor	HiFiBiO Therapeutics	P1	CC (43)
Xmab541 Testicular Germ Cell Tumor	Xencor, Inc.	P1	CC (43)
Hmpl-653 Testicular Germ Cell Tumor	Hutchison Medipharma Limited	P1	NR ()